Endo, Inc. (Endo Pharmaceuticals)

Malvern, PA
Small Molecule (Oral Solid Dose) Sterile Injectables Generics Branded Pharmaceuticals
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Endo, Inc. (Endo Pharmaceuticals)

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Malvern, PA
Modalities
Small Molecule (Oral Solid Dose), Sterile Injectables, Generics, Branded Pharmaceuticals
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Endo, Inc. (Endo Pharmaceuticals)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesSmall Molecule (Oral Solid Dose), Sterile Injectables, Generics, Branded Pharmaceuticals
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (4 modalities)

Frequently Asked Questions About Endo, Inc. (Endo Pharmaceuticals)

What is Endo, Inc. (Endo Pharmaceuticals)'s CDMO Signal Score?
Endo, Inc. (Endo Pharmaceuticals) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Endo, Inc. (Endo Pharmaceuticals) for a manufacturing program?
Use the free AI matchmaker to compare Endo, Inc. (Endo Pharmaceuticals) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Cipla Limited
Mumbai, India
Small Molecule (Oral Solid Dose), Sterile Injectables, Inhalation / MDI (Albuterol), API, Generics, Biosimilars (emerging)
Amneal Pharmaceuticals
Bridgewater, NJ
Small Molecule (Oral Solid Dose), Sterile Injectables, Biosimilars, Generic Drug Products, Blow-Fill-Seal (BFS), Ophthalmics, Inhalation (MDI/DPI)
Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines
Serán Bioscience
Bend, OR
Small Molecule (Oral Solid Dose), Spray Dried Dispersion (SDD), Hot Melt Extrusion (HME), Nano-milling / Nanoparticulate, Fluid Bed Processing, Particle Engineering, Pulmonary / Inhaled Particulates, Nasal Drug Delivery, Finished Dose (tablets, capsules, OPCs, powder-in-bottle)
Bora Pharmaceuticals
Taipei, Taiwan
Small Molecule (Oral Solid Dose), Biologics (Drug Substance & Drug Product), Monoclonal Antibody, Sterile Injectables / Aseptic Fill-Finish, Semi-Solids (creams, ointments, gels), Liquids (solutions, suspensions, ophthalmics, nasal sprays), Lyophilization